Pages with the fewest revisions

Jump to navigation Jump to search

Showing below up to 50 results in range #10,901 to #10,950.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. Neuralgia MRI (1 revision)
  2. Neuralgia case study one (1 revision)
  3. Neuralgia classification (1 revision)
  4. Neuralgia cost-effectiveness of therapy (1 revision)
  5. Neuralgia differential diagnosis (1 revision)
  6. Neuralgia future or investigational therapies (1 revision)
  7. Neuralgia historical perspective (1 revision)
  8. Neuralgia history and symptoms (1 revision)
  9. Neuralgia other imaging findings (1 revision)
  10. Neuralgia pathophysiology (1 revision)
  11. Neuralgia physical examination (1 revision)
  12. Neuralgia primary prevention (1 revision)
  13. Neuralgia screening (1 revision)
  14. Neuralgia secondary prevention (1 revision)
  15. Neuralized e3 ubiquitin protein ligase 3 (1 revision)
  16. Neurally mediated syncope (1 revision)
  17. Neuraminic acid (1 revision)
  18. Neuraminidase inhibitor (1 revision)
  19. Neuraxial blockade (1 revision)
  20. Neuraxis (1 revision)
  21. Neuregulin 2 (1 revision)
  22. Neurexophilin and pc-esterase domain family member 2 (1 revision)
  23. NeuroArm (1 revision)
  24. NeuroNames (1 revision)
  25. Neuroactive steroid (1 revision)
  26. Neuroblast (1 revision)
  27. Neuroblastoma highly expressed 1 (1 revision)
  28. Neurocalcin (1 revision)
  29. Neurocan (1 revision)
  30. Neurocardiogenic syncope causes (1 revision)
  31. Neurocardiogenic syncope risk factors (1 revision)
  32. Neurodegeneration with brain iron accumulation (1 revision)
  33. Neurodegenerative disease (1 revision)
  34. Neurodermatitis (1 revision)
  35. Neuroeconomics (1 revision)
  36. Neuroendocrine tumors natural history (1 revision)
  37. Neuroendocrine tumors secondary prevention (1 revision)
  38. Neuroendocrinology (1 revision)
  39. Neurofibroma case study one (1 revision)
  40. Neurofibroma natural history (1 revision)
  41. Neurofibromatosis type 1 cost-effectiveness of therapy (1 revision)
  42. Neurofibromatosis type 1 future or investigational therapies (1 revision)
  43. Neurofibromatosis type 1 other imaging findings (1 revision)
  44. Neurofibromatosis type 1differential diagnosis (1 revision)
  45. Neurogastroenterology (1 revision)
  46. Neurogenic locus notch homolog protein 4 (1 revision)
  47. Neurogenin-1 (1 revision)
  48. Neurogenin-2 (1 revision)
  49. Neurogenin-3 (1 revision)
  50. Neuroglycopenia (patient information) (1 revision)

View ( | ) (20 | 50 | 100 | 250 | 500)